Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Aarhus
Ain Shams University
IRCCS San Raffaele
Albert Einstein College of Medicine
Leiden University Medical Center
Shanghai Pulmonary Hospital, Shanghai, China
Rutgers, The State University of New Jersey
Massachusetts General Hospital
Fundación GECP
Medipol University
RenJi Hospital
The First Affiliated Hospital of Guangzhou Medical University
University of Alabama at Birmingham
Instituto Nacional de Cancerologia de Mexico
Boston University
Boston University
Yale University
University Hospital Bispebjerg and Frederiksberg
All India Institute of Medical Sciences, Bhubaneswar
Fundación GECP
Fundación GECP
Fundación GECP
Fundación GECP
Rigshospitalet, Denmark
Fundación GECP
Stanford University
Stanford University
University of Washington
European Institute of Oncology
Universitair Ziekenhuis Brussel
Assiut University
Insel Gruppe AG, University Hospital Bern
University of California, Irvine
Aga Khan University
McGill University Health Centre/Research Institute of the McGill University Health Centre
Azienda Sanitaria-Universitaria Integrata di Udine
Population Health Research Institute
Milton S. Hershey Medical Center
University of New Mexico
Nanfang Hospital, Southern Medical University
The University of Queensland
University Hospital Augsburg
Johannes Gutenberg University Mainz
European Institute of Oncology
Sichuan Cancer Hospital and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Fundación GECP
Medical University of Bialystok
H. Lee Moffitt Cancer Center and Research Institute